Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Body Organ Biomedical is a Taiwan-based biotechnology company specializing in the development and manufacture of regenerative medical devices. The company leverages its proprietary collagen extraction and cross-linking technologies to produce high-purity biomaterials for dental, orthopedic, and ophthalmic applications. Their product portfolio includes bone graft substitutes, resorbable membranes, and wound dressings designed to facilitate tissue repair and regeneration. Body Organ Biomedical operates under international quality standards, including GMP and ISO 13485, and distributes its products to clinical markets worldwide. The company is particularly known for its Ologen Collagen Matrix used in ophthalmic surgeries and its Bone-D series for orthopedic reconstruction.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Body Organ Biomedical.